Skip to Main Content

Paper Details

Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.
Mol Cancer Ther
7
2023
Author NameAffiliation
Martine F RousselSt. Jude Children's Research Hospital
Frederique ZindySt. Jude Children's Research Hospital
Anang A ShelatSt. Jude Children's Research Hospital
  • 1 - 3

Datasets

Release 1.2